Results

Total Results: 1,566 records

Showing results for "defined".

  1. Brooks_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/brooks_eccs2012.pdf
    January 01, 2012 - Slide 7: External Communications  Strategy • Directed media inquires to defined spokespersons. •
  2. effectivehealthcare.ahrq.gov/sites/default/files/upenn-final-report-2005-certs-ce-supplement.pdf
    January 01, 2005 - Sudden cardiac death (SCD) is defined as the sudden, abrupt loss of heart function.4 It is considered … resolved; Died without sign of disease Validation Definition: A priori, the investigators defined … Positive predictive value (PPV) was defined as the probability that the gold standard determined positivity
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/administrative-data-validity_research.pdf
    January 01, 2007 - Sudden cardiac death (SCD) is defined as the sudden, abrupt loss of heart function.4 It is considered … resolved; Died without sign of disease Validation Definition: A priori, the investigators defined … Positive predictive value (PPV) was defined as the probability that the gold standard determined positivity
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hemorrhage-postpartum_disposition-comments.pdf
    April 28, 2015 - Key Informant #1 General The population and audience are clearly defined. … The authors have not clearly defined that there are first line and second line therapies, nor that … The key questions are well defined highly relevant clinically. … Key Informant #1 Methods Methods are clearly defined and logical for this systematic review. … We have noted that the term was not clearly defined.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
    September 23, 2016 - simplifying the diagnostic criteria for schizophrenia from DSM-III through DSM-IV, without changing the defined … adverse events, time to withdrawal due to adverse events • Mortality (all-cause and cause-specific as defined … adverse events, time to withdrawal due to adverse events • Mortality (all-cause and cause-specific as defined … include all eligible interventions for the key question), include studies that meet the PICOTS as defined … bias, of individual controlled trials, systematic reviews, and observational studies by using clearly defined
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0647-13114.pdf
    June 21, 2013 - Staff-Generated PICO Population(s): Adults, defined as 18 years of age or older, diagnosed with MDD;
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/treatment-resistant-depression_research-protocol.pdf
    December 09, 2009 - For adults with treatment-resistant depression (TRD, defined as two or more failed adequate trials … • Population(s): Adults with a current episode of treatment-resistant depression (TRD, defined … • Elderly or very elderly patients; other demographic groups (defined by age, ethnic or racial groups … all races, ethnicities, cultural groups, adults Patients with treatment-resistant depression (defined
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-apps-G1-2.xlsx
    January 01, 2022 - Were Outcomes Prespecified and Defined, and Ascertained Using Accurate Methods?
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-app-G.xlsx
    January 01, 2022 - Were Outcomes Prespecified and Defined, and Ascertained Using Accurate Methods?
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-f1-f2-2022-update_0.xlsx
    January 01, 2022 - Were Outcomes Prespecified and Defined, and Ascertained Using Accurate Methods?
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
    October 05, 2018 - increased risk of fracture.[1] In 1994, a World Health Organization (WHO) Study Group operationally defined … start of drug holiday, duration of drug holiday, post-drug holiday agent/class) *Osteoporosis defined … †Osteopenia/low bone mass defined by hip or lumbar spine DXA BMD T-score < -1.0 and > -2.5. … †Osteopenia/low bone mass defined by hip or lumbar spine DXA BMD T-score < -1.0 and > -2.5. 8 … †Osteopenia/low bone mass defined by hip or lumbar spine DXA BMD T-score < -1.0 and > -2.5. 10
  12. Menopause Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
    March 01, 2015 - Menopausal Symptoms: Comparative Effectiveness of Therapies Executive Summary Background Menopause is defined … Menopausal transition is defined by variability in menstrual cycle length, followed by periods of … Perimenopause is defined as the entire menopausal transition phase, extending into the first 12 months … Do effectiveness and adverse effects vary among subgroups of participants defined by demographics, … interventions, important outcomes considered and defined, and intention- to-treat analysis.
  13. effectivehealthcare.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
    December 01, 2009 - Treatment regimens were defined based on classes dispensed. … All possible combinations were defined and patients were allocated to mutually exclusive groups. … For ICS, high doses were defined as average daily doses ≥700 µg per day.21, 22 High dose categories … Respiratory medication regimens were defined for each six month increment during follow-up. … Respiratory regimens prior to baseline were defined based on FY2002 prescriptions.
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-management_research.pdf
    December 01, 2009 - Treatment regimens were defined based on classes dispensed. … All possible combinations were defined and patients were allocated to mutually exclusive groups. … For ICS, high doses were defined as average daily doses ≥700 µg per day.21, 22 High dose categories … Respiratory medication regimens were defined for each six month increment during follow-up. … Respiratory regimens prior to baseline were defined based on FY2002 prescriptions.
  15. effectivehealthcare.ahrq.gov/sites/default/files/suppl-1-user-guide-to-ocer_130129.pdf
    January 01, 2011 - Iowa College of Pharmacy, Iowa City, IA Introduction Comparative effectiveness research (CER) is defined … In contrast, objective 5 is defined with respect to the patient subset whose choice of T relative to … At a specific T utilization rate, the patients defined in objective 5 can be thought of as a subset … of the patients defined in objective 4, except that distinct patients may be affected by distinct … If a CER objective is defined for a patient population with specific characteristics, the objective
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-decision-support-tools_disposition-comments.pdf
    December 23, 2014 - The key questions are well defined and target important unanswered questions in the field. … Can you give an example or be more clear on the difference as you defined it. Now clarified. … Would be good to clarify this outcome and how it is defined. … Was this because of how narrowly defined the search was? … Yet, KQ2 was a priori defined and we chose to show the observed lack of evidence.
  17. 8 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
    November 01, 2008 - Patient registries collect information on clinical outcomes in populations defined by a particular … note when grading severity or seriousness of adverse events is based on nonstandardized or poorly defined … of a study is sufficient, as long as particular attention is paid to how well adverse events are defined … Were the harms PRE-DEFINED using standardized or precise definitions? 2. … Were SERIOUS events precisely defined? 3. Were SEVERE events precisely defined? 4.
  18. 8 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
    November 01, 2008 - Patient registries collect information on clinical outcomes in populations defined by a particular … note when grading severity or seriousness of adverse events is based on nonstandardized or poorly defined … of a study is sufficient, as long as particular attention is paid to how well adverse events are defined … Were the harms PRE-DEFINED using standardized or precise definitions? 2. … Were SERIOUS events precisely defined? 3. Were SEVERE events precisely defined? 4.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-nomination_methods.pdf
    November 01, 2012 - A poorly defined PICO can lead to development of a topic that may miss important populations, lack … To aid topic selection decisions, a well-defined PICO should include the following— Details on the … and a well-defined PICO. … Poorly versus well-defined PICOs Poorly defined PICO: Sleep Apnea Well-defined PICO: Treatment … In this context, stakeholders are defined as clinicians, policymakers, guideline developers, professional
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
    June 01, 2013 - Often, however, some pain persists; therefore, treatment success is usually defined by a decrease in … We defined eligible intermediate and patient-centered outcomes (presented in the analytical framework … We defined treatment effect estimates as precise when pooled estimates had reasonably narrow 95% CIs … We defined high strength of evidence on the basis of consistent findings from well-designed RCTs. … Most trials defined migraine according to the International Headache Society diagnostic criteria.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: